Lisa Rojkjaer's Company Details
Encinitas, CA, US • 50 - 99 Employees
BioTech/Drugs
Viracta is focused on advancing a proprietary viral gene activation therapy to address cancers associated with the Epstein-Barr Virus, and will pursue opportunities to address other serious virus-associated disease.
Cancer
Lymphoproliferative Disorders
Nasopharyngeal Carcinoma
EBV Lymphoma
Immuno-Oncology
Oncology
Clinical
Gastric Cancer
Breast Cancer